Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

Private Market Index

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Lycera Stock

lycera.comHealthcareFounded: 1900Funding to Date: $106.06MM

Lycera is a biopharmaceutical company that seeks to uncover new small molecule therapies for the treatment of autoimmune diseases and cancer.

Learn more about Lycera IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Lycera.

Register Today

Team

Management Team

Alex Howarth

Chief Financial Officer

William Sibold

Co-Chief Executive Officer & President

Bruce Goldsmith Ph.D

Chief Operating Officer and Chief Business Officer

Paul Sekhri

President, Co-Chief Executive Officer & Board Member

H. Jeffrey Wilkins MD

Chief Medical Officer

Board Members

Jeffrey Leiden Ph.D

Blackstone Life Sciences

Michael Hayden Ph.D

Pablo Cagnoni MD

Robert Kamen Ph.D

Mary Campbell

EDF Ventures

Nina Kjellson

InterWest Partners

Paul Sekhri

Steven Gillis Ph.D

ARCH Venture Partners

Kristina Burow

ARCH Venture Partners

Nicholas Simon

Blackstone Life Sciences

Finny Kuruvilla Ph.D

Blackstone Life Sciences

Timothy Mayleben

Other companies like Lycera in the Healthcare sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$809.52MM

Colossal Biosciences

Sector

Last Round Est. Valuation

$1.01B

Sector

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Last Round Est. Valuation

$396.01MM

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$1.53B

Frequently Asked Questions

Updated on: Jun 1, 2023